Search Results - "Gancberg, David"
-
1
Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel
Published in Clinical cancer research (15-07-2008)“…Purpose: To evaluate the role of microtubule-associated variables as potential predictors of response and clinical outcome in patients with advanced breast…”
Get full text
Journal Article -
2
HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil
Published in Clinical cancer research (01-05-2002)“…Purpose: The purpose of this study is to evaluate HER-2 and topoisomerase IIα (topo IIα) as candidates for predicting the activity of anthracyclines in the…”
Get full text
Journal Article -
3
Twenty Years of European Union Support to Gene Therapy and Gene Transfer
Published in Human gene therapy (01-11-2017)“…For 20 years and throughout its research programmes, the European Union has supported the entire innovation chain for gene transfer and gene therapy. The…”
Get more information
Journal Article -
4
Quantitative determination of Roundup Ready soybean (Glycine max) extracted from highly processed flour
Published in Analytical and bioanalytical chemistry (01-09-2005)“…Roundup Ready soybean powder has been subjected to different amounts of DNA fragmentation to assess the accuracy of real-time PCR on processed food. Certified…”
Get full text
Journal Article -
5
study of comparability in amplified fragment length polymorphism profiling using a simple model system
Published in Electrophoresis (01-09-2007)“…A simple amplified fragment length polymorphism (AFLP) model, using the bacteriophage lambda genome, was developed to test the reproducibility of this…”
Get full text
Journal Article -
6
Gene and cell therapy funding opportunities in horizon 2020: an overview for 2014-2015
Published in Human gene therapy (01-03-2014)Get more information
Journal Article -
7
-
8
European Union Support of Gene Therapy Research: A Success Story
Published in Molecular therapy (01-12-2012)Get full text
Journal Article -
9
Opportunities for vaccine research in Europe
Published in Human vaccines & immunotherapeutics (03-08-2015)Get full text
Journal Article -
10
Introduction: gene and cell therapy projects of the seventh framework program
Published in Human gene therapy. Clinical development (01-06-2014)Get more information
Journal Article -
11
Chromogenic in Situ Hybridization : A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples
Published in The American journal of pathology (01-11-2000)“…Determination of HER-2/neu oncogene amplification has become necessary for selection of breast cancer patients for trastuzumab (Herceptin) therapy…”
Get full text
Journal Article -
12
Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast Carcinomas
Published in American journal of clinical pathology (01-05-2000)Get full text
Journal Article -
13
Considerations for the development of a reference method for sequencing of haploid DNA--an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory Medicine
Published in Clinical chemistry and laboratory medicine (01-11-2009)“…Following the completion of sequencing of the human genome, there has been a very rapid increase in the development of new molecular diagnostic tests. However,…”
Get more information
Journal Article -
14
European External Quality Control Study on the Competence of Laboratories to Recognize Rare Sequence Variants Resulting in Unusual Genotyping Results
Published in Clinical chemistry (Baltimore, Md.) (01-04-2009)“…Depending on the method used, rare sequence variants adjacent to the single nucleotide polymorphism (SNP) of interest may cause unusual or erroneous genotyping…”
Get full text
Journal Article -
15
Certification of reference materials for detection of the human prothrombin gene G20210A sequence variant
Published in Clinical chemistry and laboratory medicine (01-01-2008)“…There is a need for reference materials (RMs) in the field of genetic testing for verification of test results obtained in patients and probands. For the…”
Get more information
Journal Article -
16
Nucleic acid reference materials (NARMs): definitions and issues
Published in Clinical chemistry and laboratory medicine (01-11-2010)“…Molecular diagnostics is one of the most rapidly growing areas of laboratory medicine. This rapid growth of clinical molecular tests has outpaced the…”
Get more information
Journal Article -
17
Tumor‐infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome
Published in International journal of cancer (21-06-1999)“…Dendritic cells (DC) are the most potent antigen‐presenting cells, and induce antigen‐specific immune responses. Infiltration of tumors by DC is thought to…”
Get full text
Journal Article -
18
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing
Published in Breast cancer research and treatment (01-07-2002)“…This study investigated the degree of interlaboratory agreement when HER-2/neu was evaluated by immunohistochemistry (IHC) on archival primary breast cancer…”
Get full text
Journal Article -
19
Chromogenic in Situ Hybridization
Published in The American journal of pathology (01-11-2000)“…Determination of HER-2/neu oncogene amplification has become necessary for selection of breast cancer patients for trastuzumab (Herceptin) therapy…”
Get full text
Journal Article -
20
Chromogenic in Situ Hybridization: A Practical Alternative for Fluorescence
Published in The American journal of pathology (01-11-2000)“…Determination of HER-2/neu oncogene amplification has become necessary for selection of breast cancer patients for trastuzumab (Herceptin) therapy…”
Get full text
Journal Article